The safety and side effects of ENSPRYNG were studied in a diverse group of people
ENSPRYNG is a treatment that can be taken long-term, backed by a median* of 5 years of safety data
ENSPRYNG is a treatment that can be taken long-term, backed by a median* of 5 years of safety data
ENSPRYNG is a treatment that can be taken long-term, backed by a median* of 5 years of safety data
ENSPRYNG has an established safety profile, which means it has been well-studied. Two clinical studies found that side effects seen with ENSPRYNG were similar to those seen with placebo.
*A median is a numeric middle. That means that in a list of numbers, the median is the number in the middle.
†The safety population included patients who received at least 1 dose of ENSPRYNG or placebo and included AQP4-positive and AQP4-negative patients.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 800-FDA-1088. You may also report side effects to Genentech at 888-835-2555. For more information, call 844-NSPRYNG.
Backed by a median of 5 years of safety data: 106 patients who completed Study 1 or Study 2 were included in a long-term, open-label study and have been taking ENSPRYNG for a median of 5 years.‡
Long-term safety rates for ENSPRYNG were similar to rates in Study 1 and Study 2. These rates included side effects, serious side effects, infections, and serious infections.
‡An open-label study means that patients and the study staff knew ENSPRYNG was the provided treatment. Conclusions should not be drawn on the basis of an open-label study, as the results from this study were not used to support the approval of ENSPRYNG.
Hear stories from others living with NMOSD about their path from diagnosis to treatment.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.